or
forgot password

    • cancer clinical trials in burlington, NC

    • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Breast Cancer
    Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Office of Janak K. Choksi
    Burlington, North Carolina 27216
    Lung Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Endometrial Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Metastatic Cancer, Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Colorectal Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Esophageal Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Breast Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Endometrial Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Alamance Regional Cancer Center
    Burlington, North Carolina 27215
    Chronic Myeloid Leukemia
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
    Alamance Regional Cancer Center
    Burlington, North Carolina 27215
    Colorectal Cancer Metastatic
    A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
    Kernodle Clinic, Inc.
    Burlington, North Carolina 27215
    Overactive Bladder
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
    Alamance Regional Medical Center Cancer Center
    Burlington, North Carolina 27215
    Colorectal Cancer
    VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
    Alamance Regional Cancer Center
    Burlington, North Carolina 27215
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.
    For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician.
    Burlington, North Carolina
    Lung Neoplasms
    Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Head and Neck Cancer
    Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
    Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Endometrial Cancer
    Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Breast Cancer, Fatigue
    Non-small Cell Lung Cancer Registry
    Alamance Regional Medical Ctr. Cancer Ctr.
    Burlington, North Carolina 27215
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Breast Cancer, Hot Flashes
    Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer
    Alamance Oncology/Hematology Associates, LLP
    Burlington, North Carolina 27216
    Lung Cancer, Metastatic Cancer
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Soy Protein/Isoflavones and Venlafaxine in Treating Hot Flashes in Patients Receiving Hormone Therapy for Prostate Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Hot Flashes, Prostate Cancer
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Kernodle Clinic, Inc.
    Burlington, North Carolina 27215
    Atrial Fibrillation, Atrial Flutter
    L-Arginine Supplements in Treating Women Who Are Cancer Survivors
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Sexual Dysfunction, Sexuality and Reproductive Issues, Unspecified Adult Solid Tumor, Protocol Specific
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Vinflunine and Cetuximab as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Alamance Oncology/Hematology Associates, LLP
    Burlington, North Carolina 27216
    Lung Cancer
    Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen
    Sanofi-Aventis Investigational Site Number 840035
    Burlington, North Carolina 27215
    Colorectal Neoplasms, Neoplasm Metastasis
    Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Alamance Cancer Center at Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer
    Alamance Regional Medical Center-Cancer Ctr.
    Burlington, North Carolina 27215
    Non-Small Cell Lung Cancer
    Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
    Alamance Regional Medical Center
    Burlington, North Carolina 27216
    Non Small Cell Lung Cancer
    Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
    Westside OBGYN
    Burlington, North Carolina
    Influenza Vaccine, Papillomavirus Infection, Pertussis
    APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results
    Laboratory Corporation of America
    Burlington, North Carolina 27215
    Human Papillomavirus Infection
    Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System
    LabCorp Corporation of America
    Burlington, North Carolina 27215
    Human Papilloma Virus Infection
    Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System
    Laboratory Corporation of America
    Burlington, North Carolina 27215
    Human Papillomavirus Infection